Acura Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US00509L8028
Biotechnology & Medical Research
Sales 2020 | 3.57M 280M | Sales 2021 | 1.56M 122M | Capitalization | 32.54M 2.55B |
---|---|---|---|---|---|
Net income 2020 | -1M -78.34M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 459M | Net Debt 2021 | 135K 10.58M | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.19% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 06/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 28/02/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 28/02/98 |
William Skelly
BRD | Director/Board Member | 73 | 30/04/96 |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |